Giovanna Jaramillo-Gutierrez

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Mosquito immune responses and compatibility between Plasmodium parasites and anopheline mosquitoes
    Giovanna Jaramillo-Gutierrez
    Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 29892, USA
    BMC Microbiol 9:154. 2009
  2. ncbi Some strains of Plasmodium falciparum, a human malaria parasite, evade the complement-like system of Anopheles gambiae mosquitoes
    Alvaro Molina-Cruz
    Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA
    Proc Natl Acad Sci U S A 109:E1957-62. 2012
  3. ncbi The Anopheles gambiae oxidation resistance 1 (OXR1) gene regulates expression of enzymes that detoxify reactive oxygen species
    Giovanna Jaramillo-Gutierrez
    Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA
    PLoS ONE 5:e11168. 2010
  4. ncbi Reactive oxygen species modulate Anopheles gambiae immunity against bacteria and Plasmodium
    Alvaro Molina-Cruz
    Laboratory of Malaria and Vector Research, NIAID, National Institutes of Health, Rockville, Maryland 20892 8130, USA
    J Biol Chem 283:3217-23. 2008
  5. ncbi Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria
    Ivo M B Francischetti
    Section of Vector Biology, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Arterioscler Thromb Vasc Biol 32:786-98. 2012

Collaborators

Detail Information

Publications5

  1. ncbi Mosquito immune responses and compatibility between Plasmodium parasites and anopheline mosquitoes
    Giovanna Jaramillo-Gutierrez
    Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 29892, USA
    BMC Microbiol 9:154. 2009
    ....
  2. ncbi Some strains of Plasmodium falciparum, a human malaria parasite, evade the complement-like system of Anopheles gambiae mosquitoes
    Alvaro Molina-Cruz
    Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA
    Proc Natl Acad Sci U S A 109:E1957-62. 2012
    ..Evasion of the A. gambiae immune system by P. falciparum may be the result of parasite adaptation to sympatric mosquito vectors and may be an important factor driving malaria transmission...
  3. ncbi The Anopheles gambiae oxidation resistance 1 (OXR1) gene regulates expression of enzymes that detoxify reactive oxygen species
    Giovanna Jaramillo-Gutierrez
    Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA
    PLoS ONE 5:e11168. 2010
    ..The most highly conserved region of the gene is the carboxyl-terminal TLDc domain, which has been shown to be sufficient to prevent oxidative damage...
  4. ncbi Reactive oxygen species modulate Anopheles gambiae immunity against bacteria and Plasmodium
    Alvaro Molina-Cruz
    Laboratory of Malaria and Vector Research, NIAID, National Institutes of Health, Rockville, Maryland 20892 8130, USA
    J Biol Chem 283:3217-23. 2008
    ..gambiae immunity and that the mosquito response to P. berghei involves a local reduction of detoxification of hydrogen peroxide in the midgut that contributes to limit Plasmodium infection through a lytic mechanism...
  5. ncbi Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria
    Ivo M B Francischetti
    Section of Vector Biology, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Arterioscler Thromb Vasc Biol 32:786-98. 2012
    ..DF was investigated here as a drug to treat cerebral malaria...